For the Inventor, By the Inventor

Enter assignee name

Nijmegen, Netherlands

Interna Technologies B.v.

Calculating rank

USPTO Granted Patents = 8

% Expired Patents = 37.5

EPO Patents = 5

Forward Citations = 12

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Roeland Quirinus Jozef Schaapveld (8 out of 9 patents)

Willemijn Maria Gommans (6 out of 7 patents)

Eugene Berezikov (4 out of 7 patents)

4. Rick Jan Van Haastert (4 out of 5 patents)

5. Sanne Weijzen (4 out of 4 patents)

6. Petronella Innocentia Van Noort (3 out of 3 patents)

7. Grégoire Pierre André Prevost (3 out of 4 patents)

8. Jacobus Antonius Schalken (2 out of 6 patents)

9. Meriem Bourajjaj (2 out of 2 patents)

10. Arjan Willem Griffioen (2 out of 5 patents)

11. Edwin Pieter Johan Gerard Cuppen (2 out of 2 patents)

12. Andreas Alphons Franciscus Ludovicus Van Puijenbroek (2 out of 2 patents)

13. Negar Babae (2 out of 2 patents)

14. Jos Bernard Poell (1 out of 2 patents)

15. Andreas Alphons F L Van Puijenbroek (1 out of 2 patents)

8 patents: Sort by Forward Citations

1. 11497762 - MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation (2022-11-15),

2. 10201556 - Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway (2019-02-12),

3. 10174314 - MiRNA for treating head and neck cancer (2019-01-08),

4. 10023868 - MiRNA for treating diseases and conditions associated with neo-angiogenesis (2018-07-17),

5. 9944932 - MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT (2018-04-17),

6. 9682095 - MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway (2017-06-20),

7. 9441222 - MiRNA for treating diseases and conditions associated with neo-angiogenesis (2016-09-13),

8. 9161947 - MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT (2015-10-20),

Company Overview

Interna Technologies B.v. is a leading technology company specializing in providing innovative IT solutions for businesses. With a strong focus on software development, cloud services, and cybersecurity, Interna Technologies helps clients optimize their operations and enhance their digital presence. The company's team of experts is committed to delivering high-quality services to meet the unique needs of each client.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#9 in Nijmegen

#750 in Netherlands

Nijmegen, Netherlands

Interna Technologies B.v.

Forward Citations = 12

32 inventors:

Roeland Quirinus Jozef Schaapveld (8 out of 9 patents)

Willemijn Maria Gommans (6 out of 7 patents)

Eugene Berezikov (4 out of 7 patents)

4. Rick Jan Van Haastert (4 out of 5 patents)

5. Sanne Weijzen (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Interna Technologies B.v.. Retrieved from https://idiyas.com/company/interna-technologies-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…